COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
HCQ study #87 of 257
7/15 N/A
Kavanagh et al., Med. Hypotheses, doi:10.1016/j.mehy.2020.110110 (Peer Reviewed)
Inhaled hydroxychloroquine to improve efficacy and reduce harm in the treatment of COVID-19
Source   PDF   Share   Tweet
Proposal to use an inhaled formulation of HCQ which has passed safety studies in clinical trials for the treatment of asthma. Authors advocate for early treatment or prophylaxis of COVID-19, using HCQ as an inhaled aerosol, to deliver the drug directly to the lungs at a lower dose than that required for oral systemic delivery.

Kavanagh et al., 7/15/2020, peer-reviewed, 9 authors.
Details of all 257 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit